Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics

[1]  P. Nelson,et al.  Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGEN. , 2019, Cancer genetics.

[2]  T. Haferlach,et al.  Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing , 2018, Leukemia.

[3]  J. L. Fink,et al.  Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia , 2017, Molecular Cancer Research.

[4]  E. Clappier,et al.  The MLL recombinome of acute leukemias in 2017 , 2017, Leukemia.

[5]  K. Okamura,et al.  ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype , 2017, Haematologica.

[6]  F. Sartori,et al.  Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases , 2016, Experimental Hematology & Oncology.

[7]  G. Ananda,et al.  Abstract 3630: Validation of the Archer FusionPlex solid tumor panel in the JAX cancer treatment profileTM , 2016 .

[8]  B. Johansson,et al.  Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia , 2016, Nature Communications.

[9]  Somak Roy,et al.  Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. , 2016, Neuro-oncology.

[10]  Gert Matthijs,et al.  Guidelines for diagnostic next-generation sequencing , 2015, European Journal of Human Genetics.

[11]  Cheng Cheng,et al.  The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias , 2015, Nature Genetics.

[12]  L. Gorunova,et al.  Comparison between Karyotyping-FISH-Reverse Transcription PCR and RNA- Sequencing-Fusion Gene Identification Programs in the Detection of KAT6A-CREBBP in Acute Myeloid Leukemia , 2014, PloS one.

[13]  P. Sorensen,et al.  ChildSeq-RNA: A next-generation sequencing-based diagnostic assay to identify known fusion transcripts in childhood sarcomas. , 2014, The Journal of molecular diagnostics : JMD.

[14]  T. Fioretos,et al.  RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib , 2014, Leukemia.

[15]  Francisco Cervantes,et al.  European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. , 2013, Blood.

[16]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[17]  W. Choi,et al.  The MLL recombinome of acute leukemias in 2013 , 2013, Leukemia.

[18]  P. Hokland,et al.  Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission – methodologies in relation to their clinical situation , 2012, British journal of haematology.

[19]  Jolanta Grembecka,et al.  Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. , 2012, Nature chemical biology.

[20]  Yonghong Xiao,et al.  Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. , 2011, Cancer cell.

[21]  R. Marschalek,et al.  TEL/AML1‐positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases , 2011, Pediatric blood & cancer.

[22]  N. Shinton.  WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[23]  M. D. Boer,et al.  The MLL recombinome of acute leukemias , 2006, Leukemia.

[24]  D. Liang,et al.  Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement , 2006, Leukemia.

[25]  M. Caligiuri,et al.  Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Ōmura,et al.  Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. , 1996, Cancer research.

[27]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[28]  J. Choi,et al.  Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies. , 2019, The Journal of molecular diagnostics : JMD.

[29]  K. Inokuchi,et al.  Acute Leukemia : Update of Clinical Aspects , 2010 .

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..